Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteogenomics | 12 | 2024 | 69 | 2.530 |
Why?
|
| Breast Neoplasms | 17 | 2024 | 2519 | 1.940 |
Why?
|
| Estrogen Receptor alpha | 6 | 2023 | 458 | 0.990 |
Why?
|
| Drug Resistance, Neoplasm | 4 | 2024 | 733 | 0.890 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2021 | 257 | 0.740 |
Why?
|
| Triple Negative Breast Neoplasms | 5 | 2025 | 234 | 0.740 |
Why?
|
| Endocytosis | 3 | 2011 | 125 | 0.710 |
Why?
|
| Receptors, Estrogen | 5 | 2024 | 794 | 0.660 |
Why?
|
| Neoplasms | 6 | 2024 | 2800 | 0.650 |
Why?
|
| Proteomics | 11 | 2025 | 507 | 0.630 |
Why?
|
| Antineoplastic Agents | 4 | 2024 | 1714 | 0.620 |
Why?
|
| Gene Fusion | 1 | 2018 | 57 | 0.580 |
Why?
|
| Receptors, Interleukin-5 | 2 | 2008 | 4 | 0.570 |
Why?
|
| Signal Transduction | 8 | 2021 | 4595 | 0.420 |
Why?
|
| Lysine | 2 | 2011 | 200 | 0.420 |
Why?
|
| Cyclin-Dependent Kinase 6 | 3 | 2024 | 44 | 0.410 |
Why?
|
| Cyclin-Dependent Kinase 4 | 3 | 2024 | 59 | 0.410 |
Why?
|
| Ubiquitination | 2 | 2021 | 170 | 0.400 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2011 | 1 | 0.380 |
Why?
|
| Janus Kinase 1 | 1 | 2011 | 11 | 0.380 |
Why?
|
| Molecular Targeted Therapy | 3 | 2024 | 375 | 0.340 |
Why?
|
| Eosinophils | 2 | 2008 | 120 | 0.340 |
Why?
|
| Janus Kinase 2 | 1 | 2011 | 131 | 0.340 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2021 | 216 | 0.330 |
Why?
|
| Precision Medicine | 2 | 2023 | 321 | 0.310 |
Why?
|
| Transferrin | 1 | 2008 | 49 | 0.300 |
Why?
|
| src-Family Kinases | 2 | 2016 | 91 | 0.290 |
Why?
|
| Mutation | 8 | 2024 | 5903 | 0.280 |
Why?
|
| Protein Kinases | 3 | 2025 | 331 | 0.280 |
Why?
|
| Janus Kinases | 1 | 2007 | 31 | 0.270 |
Why?
|
| Humans | 36 | 2025 | 125438 | 0.260 |
Why?
|
| Ubiquitin | 1 | 2007 | 142 | 0.250 |
Why?
|
| Cell Line, Tumor | 8 | 2025 | 3419 | 0.250 |
Why?
|
| Zona Pellucida Glycoproteins | 1 | 2025 | 9 | 0.240 |
Why?
|
| Neoadjuvant Therapy | 2 | 2024 | 344 | 0.240 |
Why?
|
| Phosphoproteins | 2 | 2025 | 420 | 0.230 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2022 | 85 | 0.230 |
Why?
|
| Phenylthiohydantoin | 1 | 2024 | 12 | 0.230 |
Why?
|
| Down-Regulation | 1 | 2007 | 691 | 0.230 |
Why?
|
| Female | 23 | 2025 | 66887 | 0.220 |
Why?
|
| Neurofibromin 1 | 2 | 2023 | 42 | 0.220 |
Why?
|
| Benzamides | 1 | 2024 | 110 | 0.220 |
Why?
|
| Paclitaxel | 1 | 2024 | 130 | 0.210 |
Why?
|
| Nitriles | 1 | 2024 | 146 | 0.210 |
Why?
|
| Tumor Microenvironment | 4 | 2024 | 565 | 0.200 |
Why?
|
| Software | 2 | 2025 | 687 | 0.200 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 99 | 0.190 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2022 | 63 | 0.190 |
Why?
|
| Mass Spectrometry | 2 | 2021 | 335 | 0.190 |
Why?
|
| Machine Learning | 1 | 2024 | 251 | 0.190 |
Why?
|
| Proteome | 1 | 2023 | 246 | 0.190 |
Why?
|
| Metformin | 1 | 2023 | 150 | 0.190 |
Why?
|
| Phosphorylation | 5 | 2025 | 1638 | 0.180 |
Why?
|
| Receptors, Androgen | 1 | 2024 | 414 | 0.180 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 1756 | 0.180 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2372 | 0.170 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 1244 | 0.170 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2025 | 914 | 0.170 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 214 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 1980 | 0.160 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 115 | 0.160 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2025 | 543 | 0.160 |
Why?
|
| Genomics | 4 | 2023 | 1520 | 0.160 |
Why?
|
| Claudins | 1 | 2018 | 29 | 0.150 |
Why?
|
| Databases, Factual | 1 | 2024 | 1174 | 0.150 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2025 | 832 | 0.150 |
Why?
|
| Mitosis | 1 | 2018 | 241 | 0.140 |
Why?
|
| MutL Proteins | 1 | 2017 | 19 | 0.140 |
Why?
|
| Carcinogenesis | 1 | 2020 | 340 | 0.140 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2017 | 36 | 0.140 |
Why?
|
| Biomarkers, Tumor | 2 | 2024 | 1534 | 0.140 |
Why?
|
| Prognosis | 2 | 2023 | 4690 | 0.130 |
Why?
|
| Papillomavirus Infections | 1 | 2021 | 296 | 0.130 |
Why?
|
| Protein Binding | 3 | 2021 | 1755 | 0.130 |
Why?
|
| Transfection | 1 | 2018 | 1076 | 0.130 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 669 | 0.130 |
Why?
|
| Muscle Proteins | 1 | 2018 | 413 | 0.120 |
Why?
|
| Mammary Glands, Human | 1 | 2016 | 79 | 0.120 |
Why?
|
| Cell Movement | 1 | 2018 | 854 | 0.120 |
Why?
|
| Mice, Nude | 3 | 2021 | 725 | 0.110 |
Why?
|
| MCF-7 Cells | 3 | 2020 | 222 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 963 | 0.110 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 1316 | 0.110 |
Why?
|
| Immunotherapy | 3 | 2024 | 678 | 0.100 |
Why?
|
| Endosomes | 1 | 2011 | 64 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1654 | 0.090 |
Why?
|
| Animals | 9 | 2025 | 34309 | 0.090 |
Why?
|
| Protein Transport | 1 | 2011 | 369 | 0.090 |
Why?
|
| Mice | 6 | 2025 | 17744 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2011 | 739 | 0.080 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 5 | 0.080 |
Why?
|
| Pulmonary Alveolar Proteinosis | 1 | 2008 | 6 | 0.080 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 2008 | 13 | 0.080 |
Why?
|
| Clathrin | 1 | 2008 | 24 | 0.070 |
Why?
|
| Cholera Toxin | 1 | 2008 | 49 | 0.070 |
Why?
|
| Interleukin-5 | 1 | 2008 | 43 | 0.070 |
Why?
|
| Cell Cycle | 2 | 2023 | 627 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2023 | 12303 | 0.070 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 158 | 0.070 |
Why?
|
| Aged | 5 | 2024 | 19739 | 0.070 |
Why?
|
| ErbB Receptors | 2 | 2021 | 283 | 0.070 |
Why?
|
| p21-Activated Kinases | 2 | 2018 | 57 | 0.070 |
Why?
|
| Tyrphostins | 1 | 2007 | 13 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2023 | 2812 | 0.070 |
Why?
|
| Apoptosis | 2 | 2024 | 1817 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2008 | 464 | 0.060 |
Why?
|
| Cytoplasm | 1 | 2007 | 296 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2008 | 802 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 6558 | 0.060 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 262 | 0.060 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2022 | 772 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2022 | 746 | 0.060 |
Why?
|
| Receptor, ErbB-2 | 2 | 2020 | 514 | 0.060 |
Why?
|
| Middle Aged | 5 | 2024 | 26827 | 0.060 |
Why?
|
| Single-Chain Antibodies | 1 | 2025 | 44 | 0.060 |
Why?
|
| Protein Interaction Maps | 1 | 2024 | 79 | 0.060 |
Why?
|
| Benchmarking | 1 | 2025 | 137 | 0.060 |
Why?
|
| Phosphopeptides | 1 | 2023 | 27 | 0.060 |
Why?
|
| Adult | 5 | 2024 | 29635 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 587 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4406 | 0.050 |
Why?
|
| Knowledge Bases | 1 | 2023 | 36 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2024 | 214 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 158 | 0.050 |
Why?
|
| NFI Transcription Factors | 1 | 2023 | 50 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 91 | 0.050 |
Why?
|
| Purines | 1 | 2023 | 116 | 0.050 |
Why?
|
| Pyridines | 1 | 2024 | 235 | 0.050 |
Why?
|
| X-ray Repair Cross Complementing Protein 1 | 1 | 2022 | 21 | 0.050 |
Why?
|
| Epidermal Growth Factor | 1 | 2023 | 123 | 0.050 |
Why?
|
| Piperazines | 1 | 2024 | 242 | 0.050 |
Why?
|
| Carboplatin | 1 | 2022 | 77 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 114 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2024 | 363 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 214 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2024 | 384 | 0.050 |
Why?
|
| Cell Division | 1 | 2023 | 780 | 0.050 |
Why?
|
| GTP Phosphohydrolases | 1 | 2022 | 147 | 0.050 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 1 | 2021 | 19 | 0.050 |
Why?
|
| Cell Line | 1 | 2007 | 2755 | 0.050 |
Why?
|
| Models, Biological | 1 | 2007 | 1466 | 0.050 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2021 | 33 | 0.050 |
Why?
|
| APOBEC Deaminases | 1 | 2020 | 6 | 0.040 |
Why?
|
| Acetylation | 1 | 2021 | 168 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2007 | 3043 | 0.040 |
Why?
|
| Peptides | 1 | 2024 | 812 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 493 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2022 | 625 | 0.040 |
Why?
|
| Retinoblastoma Protein | 1 | 2020 | 81 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2020 | 4843 | 0.040 |
Why?
|
| Computational Biology | 1 | 2025 | 819 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 405 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 37 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 1077 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 200 | 0.040 |
Why?
|
| Estrogen Antagonists | 1 | 2020 | 104 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2020 | 345 | 0.040 |
Why?
|
| Clinical Trials as Topic | 1 | 2024 | 1104 | 0.040 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2019 | 37 | 0.040 |
Why?
|
| ras Proteins | 1 | 2020 | 139 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2018 | 7 | 0.040 |
Why?
|
| Brazil | 1 | 2019 | 123 | 0.040 |
Why?
|
| Snail Family Transcription Factors | 1 | 2018 | 25 | 0.040 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2018 | 26 | 0.040 |
Why?
|
| Twist-Related Protein 1 | 1 | 2018 | 36 | 0.040 |
Why?
|
| Feedback, Physiological | 1 | 2018 | 69 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2020 | 586 | 0.040 |
Why?
|
| Vimentin | 1 | 2018 | 66 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2020 | 363 | 0.040 |
Why?
|
| Heterografts | 1 | 2018 | 175 | 0.040 |
Why?
|
| Algorithms | 1 | 2025 | 1633 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2023 | 1034 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 367 | 0.040 |
Why?
|
| DNA Damage | 1 | 2020 | 516 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2020 | 680 | 0.030 |
Why?
|
| DNA Repair | 1 | 2020 | 591 | 0.030 |
Why?
|
| Metabolomics | 1 | 2020 | 422 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 681 | 0.030 |
Why?
|
| Aromatase Inhibitors | 1 | 2017 | 76 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 383 | 0.030 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2016 | 16 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 2050 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2016 | 25 | 0.030 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2083 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 486 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 358 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 89 | 0.030 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 74 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2019 | 1033 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 148 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2016 | 120 | 0.030 |
Why?
|
| Transcriptome | 1 | 2021 | 977 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2022 | 1538 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 326 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 339 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2018 | 826 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2016 | 296 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2016 | 652 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2018 | 1705 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2023 | 6174 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1284 | 0.020 |
Why?
|
| CD11b Antigen | 1 | 2008 | 36 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2008 | 43 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 69 | 0.020 |
Why?
|
| Turner Syndrome | 1 | 2008 | 45 | 0.020 |
Why?
|
| Karyotyping | 1 | 2008 | 323 | 0.020 |
Why?
|
| Male | 3 | 2021 | 61626 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 9085 | 0.020 |
Why?
|
| Monocytes | 1 | 2008 | 345 | 0.020 |
Why?
|
| Exons | 1 | 2008 | 801 | 0.020 |
Why?
|
| Genotype | 1 | 2008 | 2569 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2008 | 14142 | 0.010 |
Why?
|